Amantadine for Treatment of Symptoms of the Post-traumatic Confusional State
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Mark Sherer, Ph.D.
Department of Research, Memorial Hermann/TIRR, Houston, TX
Study Director - Risa N Richardson, Ph.D.
Polytrauma Program, James A. Haley Veterans Hospital, Tampa, FL
Study Director - Stuart A Yablon, M.D.
Brain Injury Program, Methodist Rehabilitation Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Methodist Rehabilitation Center
Jackson, Mississippi, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Apr 2003
- Primary completion
- 30 Nov 2007
- Completion
- 31 Mar 2019
- Last update posted
- 18 Oct 2023
- Registered enrollment
- 79
- Registry id
- NCT00693121
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 18 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.